Skip to content

Effect of selenium on covid-19 disease

Investigating the effectiveness of selenium on recovery of hospitalized patients with COVID-19

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190418043307N1
Enrollment
100
Registered
2020-05-17
Start date
2020-04-26
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: In addition to the standard protocol treatment, patients in the intervention group will receive 200 micrograms selenium daily for at least 2 weeks. Routine blood te

Sponsors

Deputy Dean of Research and Technology, Ilam university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of COVID-19 by RT-PCR test Respiratory rate above 30 bar per minute Percentage of peripheral blood oxygen saturation less than 90% Relative oxygen depletion ratio to arterial oxygen saturation less than 300 mm Hg Interloquin six blood levels higher Abnormally age over 18 years

Exclusion criteria

Exclusion criteria: chronic kidney disease acute kidney failure Pregnancy or lactation History of drug allergy Pneumonia caused by H influenza, viral infections, bacterial infections, fungi; and other noninfectious types of pneumonia Chronic liver disease history of latent or active tuberculosis patients with acquired immunodeficiency syndrome

Design outcomes

Primary

MeasureTime frame
Ferritin changes. Timepoint: Daily. Method of measurement: Laboratory.;Platelet. Timepoint: Daily. Method of measurement: Laboratory.;CRP. Timepoint: Daily. Method of measurement: Laboratory.;WBC changes. Timepoint: Daily. Method of measurement: Laboratory.

Secondary

MeasureTime frame
Reduced mortality. Timepoint: Day 1 to 14. Method of measurement: Record the time of death.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Nazari

Ilam University of Medical Sciences

nazari-a@medilam.ac.ir+98 84 3222 3721

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026